U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579481) titled 'Vortioxetine in Depression and Concomitant Migraine' on Nov. 21, 2024.
Brief Summary: Depression and migraine are among the most prevalent conditions in the general population, and many research shows they are closely related. Migraine is one of the most common debilitating diseases, affecting over one billion people worldwide. Migraine is frequently comorbid with psychiatric conditions such as anxiety disorders and major depression, with a negative impact on quality of life (QoL) and disability.
The knowledge of the pathophysiology of migraine involves changes in physiological processes, functional connectivity, and structural chan...